IGF-1 LR3 1mg

Description

IGF-1 LR3 1 mg is a modified Insulin-like Growth Factor-1 analogue under investigation in cell-proliferation, muscle-biology, and IGF-axis research. The LR3 modification extends the working half-life in research models.

Research Profile

• Modified IGF-1 analogue (Long R3)
• Studied in IGF-axis, cell-proliferation, and tissue-biology research
• Long history of academic research in growth and development
• QC verified by HPLC and mass spectrometry

Specifications

• Compound: IGF-1 LR3
• Dosage: 1 mg per vial
• Purity: ≥ 98% (HPLC)
• Form: Lyophilized powder
• Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)

For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.